Monopar Therapeutics
MNPR
MNPR
56 hedge funds and large institutions have $354M invested in Monopar Therapeutics in 2025 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18.33% more ownership
Funds ownership: 51.94% → 70.28% (+18%)
Holders
56
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$10.3M | |
| 2 | +$7.14M | |
| 3 | +$6.95M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$6.84M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.44M |
Top Sellers
| 1 | -$3.72M | |
| 2 | -$621K | |
| 3 | -$535K | |
| 4 |
Millennium Management
New York
|
-$333K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$223K |
